English | Español

Biospace
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
Patient Daily | Jan 27, 2026

Biotech firms emphasize regulatory alignment amid ongoing uncertainty after recent FDA reversals
Patient Daily | Jan 27, 2026

Baseline Therapeutics launches phase III trials targeting addiction with GLP-1 drug
Patient Daily | Jan 27, 2026

Biopharma leaders express optimism at JPM26 despite absence of major deals
Patient Daily | Jan 26, 2026

Rare disease biotechs face loss if priority review voucher program remains lapsed
Patient Daily | Jan 26, 2026

Five experimental treatments could reshape future care for Parkinson's disease
Patient Daily | Jan 23, 2026

Biogen outlines Alzheimer's expansion plans following Leqembi launch
Patient Daily | Jan 23, 2026

Gilead highlights HIV advances and oncology ambitions at JPM healthcare conference

Trending
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research